Stable Israeli Focus Longstanding presence in the Israeli pharmaceutical market since 1937 presents a stable, local partner with established distribution channels and physician relationships to accelerate market expansion for medicines and medical devices.

Mid-size Advantage With 51-200 employees, Rafa sits in a nimble size range that can adapt quickly to contract manufacturing opportunities, private label partnerships or pilot programs for new formulations or delivery systems.

Digital Outreach Active tech stack including Google Ads, Hotjar, AWS, Drupal and Mailchimp indicates readiness for data-driven marketing, e-commerce enabled services, and targeted campaigns to promote new products or device lines.

Growth Potential Revenue in the mid-range suggests room for scale through expanded product portfolio, additional regulatory approvals, and regional expansion within or beyond Israel, leveraging existing manufacturing capabilities.

Strategic Partnerships Opportunity to pursue co-development, contract manufacturing, or distribution partnerships with larger healthcare players seeking Israeli supply and quality assurances, backed by Rafa’s quality focus and market presence.